Concepedia

Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs

Susan M. Chang, John G. Kuhn, Patrick Y. Wen, Harry S. Greenberg, David Schiff, Charles A. Conrad, Karen Fink, H. Ian Robins, Timothy F. Cloughesy, Lisa De Angelis,

Investigational New Drugs · 2004 · 93 citations · 17 references

DOIFull text

Open access

Concepts

References

17

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

Chris J. Vlahos, William F. Matter, K. Y. Hui et al. · Journal of Biological Chemistry · 1994 · 3.2K citations · Full text

, , +16

Response criteria for phase II studies of supratentorial malignant glioma.

David R. Macdonald, T L Cascino, S. Clifford Schold et al. · Journal of Clinical Oncology · 1990 · 2.4K citations

, , +20

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR

Mehran S. Neshat, Ingo K. Mellinghoff, Chris Tran et al. · Proceedings of the National Academy of Sciences · 2001 · 973 citations · Full text

Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason et al. · Journal of Clinical Oncology · 1999 · 895 citations

Proceedings of the American Association for Cancer Research.

Erik J M Konings, Piet A. van den Brandt, Wim H. M. Saris et al. · 2001 · 770 citations

, , +9